EUVIMEDEUVIMED entdecken
Crossref

Harnessing the innate immune system by revolutionizing macrophage-mediated cancer immunotherapy

Gayatri Reghu, Praveen Kumar Vemula, Sarita Ganapathy Bhat, Sreeja Narayanan

Journal of Biosciences · 04.06.2024 · 49 (2)

DOI: 10.1007/s12038-024-00441-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biosciences, online erschienen am 04.06.2024. Verfasst von Gayatri Reghu und 3 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: The Wellcome Trust DBT India Alliance.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunotherapy is a promising and safer alternative to conventional cancer therapies. It involves adaptive T-cell therapy, cancer vaccines, monoclonal antibodies, immune checkpoint blockade (ICB), and chimeric antigen receptor (CAR) based therapies. However, most of these modalities encounter restrictions in solid tumours owing to a dense, highly hypoxic and immune-suppressive microenvironment as well as the heterogeneity of tumour antigens. The elevated intra-tumoural pressure and mutational rates within fast-growing solid tumours present challenges in efficient drug targeting and delivery. The tumour microenvironment is a dynamic niche infiltrated by a variety of immune cells, most of which are macrophages. Since they form a part of the innate immune system, targeting macrophages has become a plausible immunotherapeutic approach. In this review, we discuss several versatile approaches (both at pre-clinical and clinical stages) such as the direct killing of tumour-associated macrophages, reprogramming pro-tumour macrophages to anti-tumour phenotypes, inhibition of macrophage recruitment into the tumour microenvironment, novel CAR macrophages, and genetically engineered macrophages that have been devised thus far. These strategies comprise a strong and adaptable macrophage-toolkit in the ongoing fight against cancer and by understanding their significance, we may unlock the full potential of these immune cells in cancer therapy.

Förderung

  • The Wellcome Trust DBT India Alliance

Zitieren

APA

Reghu, G., Vemula, P. K., Bhat, S. G., & Narayanan, S. (2024). Harnessing the innate immune system by revolutionizing macrophage-mediated cancer immunotherapy. Journal of Biosciences, 49(2). https://doi.org/10.1007/s12038-024-00441-y

Vancouver

Reghu G, Vemula PK, Bhat SG, Narayanan S. Harnessing the innate immune system by revolutionizing macrophage-mediated cancer immunotherapy. Journal of Biosciences. 2024;49(2). doi:10.1007/s12038-024-00441-y

BibTeX
@article{Reghu2024,
  author = {Reghu, Gayatri and Vemula, Praveen Kumar and Bhat, Sarita Ganapathy and Narayanan, Sreeja},
  title = {Harnessing the innate immune system by revolutionizing macrophage-mediated cancer immunotherapy},
  journal = {Journal of Biosciences},
  year = {2024},
  volume = {49},
  number = {2},
  doi = {10.1007/s12038-024-00441-y}
}
Kostenlos starten →